COVID-19 vaccine "safety signal" has been identified and is investigating whether the Bivalent Pfizer-BioNTech vaccine creates an increased risk of ischemic stroke in people 65 and older.In the statement, the CDC says that the preliminary signal hasn't been identified with Bivalent Moderna COVID-19 vaccine."Following the availability and use of the updated (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent." "Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-44 following vaccination," the CDC said in a statement Friday.
FILE - A doctor vaccinates a woman with the new COVID-19 booster from the Pfizer-Biontech company. COVID XBB.1.5 VARIANT NOW ACCOUNTS FOR 43% OF ALL US CASES, CDC SAYSIn the statement, the CDC pointed out that a large study of updated bivalent vaccines from Pfizer-BioNTech "using the Centers for Medicare and Medicaid Services database revealed no increased risk of ischemic stroke."The agency also said that the Vaccine Adverse Event Reporting System (VAERS) managed by CDC and FDA has not seen an increase in reporting of ischemic strokes following the updated (bivalent) vaccine.In a statement to Fox News Digital, a spokesperson for Pfizer said "Pfizer and BioNTech have been made aware of limited reports of ischemic stroke that.